Best Grants for Rare Diseases in Tennessee

The Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program, supported by the National Institute of Allergy and Infectious Diseases (NIAID), aims to enhance research on asthma and related allergic diseases. This initiative fosters multi-center, multidisciplinary research to explore disease mechanisms and treatment responses. By promoting clinical trials and observational studies, the AADCRC seeks to advance understanding and improve interventions for conditions such as asthma and food allergies, ultimately benefiting public health.

The US Flu Vaccine Effectiveness (VE) Network aims to enhance the effectiveness of vaccines against influenza and other respiratory pathogens, which are significant contributors to morbidity and mortality. This funding opportunity invites proposals for surveillance studies, including annual VE assessments, acute respiratory illness tracking, household transmission research, and immunogenicity studies. Applicants can apply for either Component A or B, with the option to include additional components based on their primary selection.

The ARS New Investigator Research Grant aims to support innovative research in rhinology, including basic, translational, and clinical projects. The funding period is non-renewable and lasts up to 24 months. Eligible candidates include American Rhinologic Society members who have completed residency and lack significant prior funding. The number of grants awarded is contingent upon the merit of applications received, as determined by the ARS Board of Directors. This grant provides a unique opportunity for emerging researchers in the field.

The ASPO Dustin Micah Harper Recurrent Respiratory Papillomatosis Research Grant supports innovative research projects focused on recurrent respiratory papillomatosis (RRP). This grant encourages clinical and translational studies that aim to improve prevention, diagnosis, treatment, and understanding of RRP. Eligible candidates include medical professionals and researchers in the U.S. and Canada. This funding opportunity prioritizes junior faculty who have recently completed their training, fostering new insights in RRP research.

Sanofi Philanthropic Donations support non-profit organizations aligned with Health Equity, STEM Education Equity, and Local Communities. Applications are accepted year-round, with a review process of 8 to 16 weeks. The initiative focuses on improving healthcare access, fostering innovation, and addressing social determinants of health. Sanofi emphasizes collaboration and sustainable solutions, advocating for equal opportunities in health and education, and nurturing future talent to tackle medical challenges.

Gilead North America Grants support community-informed programs that enhance healthcare for vulnerable populations. Grants are available for innovative projects addressing HIV, liver diseases, oncology, and inflammatory diseases. Applications are invited from tax-exempt nonprofits based in the U.S. who focus on health equity and community engagement. Gilead prioritizes funding for projects that demonstrate a strong capability to deliver impactful outcomes, helping to eliminate barriers to healthcare and improve access to essential services.

Biogen Corporate Sponsorships provide funding to support congresses, events, and initiatives in exchange for tangible benefits such as marketing opportunities and recognition. Applications are reviewed on a rolling basis, and requests must be submitted 50 days in advance. Biogen considers various disease areas for sponsorship, including Alzheimer’s and Multiple Sclerosis. Approval depends on funding availability, alignment with interests, and event details, ensuring transparency for all potential sponsors.

The Parker B. Francis Fellowship for Pulmonary Research offers three years of funding, totaling $225,000, for clinical and basic scientists transitioning to independent research careers in pulmonary and critical care medicine. Eligible candidates include those with relevant doctoral degrees, U.S. or Canadian citizenship, and a track record of research experience. The fellowship encourages diverse research topics, including bioethics in pulmonary medicine, while requiring mentorship and adherence to strict eligibility criteria.

The LAM Foundation offers Pilot and Feasibility Research Awards aimed at fostering innovative research in lymphangioleiomyomatosis (LAM). These awards support hypothesis-driven studies with the potential to advance understanding and treatment options for this rare disease. Applicants can request a maximum of $50,000 for a period of up to one year. The Foundation prioritizes new researchers, encouraging fresh perspectives in LAM research to enhance patient care and ultimately achieve a future without LAM.

The Allergic Respiratory Diseases Award, supported by the American Lung Association and the American Academy of Allergy, Asthma & Immunology, aims to bolster research in allergic respiratory diseases. Designed for faculty in Clinical Allergy and Immunology at academic medical centers, this award offers $75,000 annually for up to two years. It seeks to empower researchers at pivotal points in their careers, enhancing understanding and treatment of these conditions while promoting lung health.

The Catalyst Award, offered by the American Lung Association, supports innovative research on lung disease and biology. This mentored grant provides $50,000 annually for up to two years, prioritizing novel projects with collaborative training plans. The American Lung Association aims to improve lung health and prevent diseases through research, education, and advocacy, focusing on defeating lung cancer and fostering a tobacco-free future.

The Emerging Respiratory Pathogen Award, offered by the American Lung Association, aims to enhance our understanding of respiratory infections' pathobiology and their implications. This award supports innovative research addressing the biology of respiratory viruses, host response factors, community spread dynamics of COVID-19, and long-term effects of viral infections. With a funding of $100,000 per year for two years, this initiative encourages groundbreaking studies to improve lung health and disease outcomes.

The Innovation Award by the American Lung Association offers $75,000 annually for up to two years, aimed at supporting promising investigators in lung disease research. With a legacy of over 120 years, the Association seeks to fund innovative projects that can significantly impact lung health. Eligible candidates must demonstrate prior excellence in their careers and have held a K or R type award within the last three to five years. This initiative fosters groundbreaking advancements in lung disease science.

The Public Policy & Public Health Award by the American Lung Association aims to foster innovative research addressing critical public health issues impacting lung health. This grant, with a maximum award of $50,000 per year for up to two years, supports researchers in various disciplines to evaluate existing policies and propose new ideas. It encourages efforts to improve air quality and tackle lung disease, aligning with the mission of enhancing public health through informed policy-making.

The William F. Miller, MD Postgraduate Education Recognition Award, offered by the American Respiratory Care Foundation, provides up to $5,000 to support respiratory therapists pursuing advanced degrees. Established in 1992, this award aims to foster education and professional growth in respiratory care. Recipients also receive recognition, airfare, lodging, and congress registration. Eligible applicants must meet specific educational and recommendation requirements, ensuring that deserving candidates are selected for this prestigious award.

The NBRC Gareth B. Gish Memorial Postgraduate Education Recognition Award, offered by the American Respiratory Care Foundation, honors the legacy of Gareth B. Gish, a pioneer in respiratory care. This award supports respiratory therapists pursuing advanced degrees, providing up to $5,000 in funding, along with recognition, airfare, lodging, and Congress registration. Established in 1999, it seeks to nurture future leaders in the field, continuing Mr. Gish's commitment to education and excellence in respiratory care.

The Charles D. McArthur Memorial Scholarship recognizes outstanding third and fourth-year students in accredited respiratory therapy programs. Funded by the American Respiratory Care Foundation, this award honors Charlie McArthur's legacy as a dedicated educator in respiratory care. Recipients may receive up to $1,000, including a certificate, travel, and registration for AARC Congress. Preference is given to Native American students or those from Minnesota, fostering diversity in the field of respiratory therapy.

The NBRC William W. Burgin, Jr., MD and Robert M. Lawrence, MD Education Recognition Award, offered by the American Respiratory Care Foundation, provides up to $7,500 to third or fourth-year students in accredited respiratory therapy programs. This prestigious award includes a recognition certificate, travel expenses, and registration for the AARC Congress, supporting future leaders in respiratory care. Eligible students must demonstrate academic excellence and obtain letters of recommendation to showcase their potential.

The Jimmy A. Young Memorial Education Recognition Award, offered by the American Respiratory Care Foundation, honors contributions to respiratory care education. Up to $1,000 is available for students enrolled in accredited respiratory care programs, provided they meet GPA requirements and submit necessary recommendations. This award includes a certificate, airfare, lodging, and registration for the AARC Congress, aiming to support deserving candidates in their educational pursuits.

The Morton B. Duggan, Jr. Memorial Education Recognition Award, provided by the American Respiratory Care Foundation, honors a student enrolled in an accredited respiratory care program. This award, which can reach up to $1,000, includes a certificate of recognition, travel expenses, and registration for AARC Congress. Eligible applicants must verify their enrollment and GPA, and provide letters of recommendation. Preference is given to candidates from Georgia and South Carolina.

The External Collaborative Research (ECR) program by Boehringer Ingelheim invites academic and community scientists to propose collaborative studies aimed at protocol development and result publication. This program offers potential drug and financial support, excluding direct salary for the Principal Investigator. Budgets must represent fair market value and will be negotiated further. Research interests span therapeutic areas including Cardio-Renal-Metabolic, Mental Health, Dermatology, and Oncology, encouraging innovative solutions to unmet medical needs.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on Pulmonary Arterial Hypertension and supports nonprofit organizations that enhance patient access to treatment and services. Eligible applicants must be IRS 501(c)(3) certified and prioritize innovative programs with measurable outcomes. Funding is aimed at addressing health disparities and improving patient care through education, advocacy, and direct services. Applications are accepted from January 1 to October 15, with a preference for initiatives over event-based requests.

The NIDCD Mentored Research Education Pathway (R25) aims to enhance research education for otolaryngology residents and medical students. This program provides essential career development activities and mentored research experiences, fostering a new generation of researchers in biomedical and clinical sciences. By focusing on specialized training, it supports the recruitment of individuals from diverse backgrounds into impactful research careers, ultimately benefiting the field of otolaryngology and related health sciences.

This funding opportunity announcement (FOA) aims to support research that advances the development of medical products for preventing, diagnosing, treating, or curing ALS and other rare neurodegenerative diseases. The FDA seeks to address critical knowledge gaps and significantly impact these diseases through this initiative, which targets both adult and pediatric populations. By funding these studies, the FDA hopes to inform current and future product development in this vital area of healthcare.

The US Department of Health & Human Services, through the FDA, is funding clinical trials targeting rare neurodegenerative diseases. This initiative aims to enhance treatment options by evaluating the efficacy and safety of new products for both children and adults. By fostering innovative and collaborative trial designs, the FDA seeks to accelerate the approval of new therapies, ultimately benefiting patients with rare conditions and advancing drug development in this critical area.

The Myocarditis Foundation offers research grants aimed at advancing the understanding and treatment of myocarditis, a rare but serious disease. These grants provide $40,000 in seed funding for promising physician-scientists within ten years of their MD or PhD. Recipients are expected to conduct research in the U.S. or Canada, culminating in a final report. The goal is to support innovative research that can lead to significant breakthroughs and ultimately, a cure for myocarditis.

Stealth Biotherapeutics offers grants and sponsorships aimed at enhancing healthcare education for providers and patient communities. These funding opportunities focus on innovative programs that address rare genetic disorders, neurodegenerative conditions, and ophthalmic disorders. To apply, requests must be submitted 60 days prior to the funding start date, ensuring alignment with the therapeutic interests of the organization while providing valuable insights for healthcare professionals.